{"id":53315,"date":"2012-10-02T14:26:56","date_gmt":"2012-10-02T14:26:56","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/abakan-files-for-nasdaqtm-capital-market-listing.php"},"modified":"2012-10-02T14:26:56","modified_gmt":"2012-10-02T14:26:56","slug":"abakan-files-for-nasdaqtm-capital-market-listing","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanotechnology\/abakan-files-for-nasdaqtm-capital-market-listing.php","title":{"rendered":"Abakan Files for NASDAQ(TM) Capital Market Listing"},"content":{"rendered":"<p><p>      MIAMI, Fla., Oct. 1, 2012 (GLOBE NEWSWIRE) --       Abakan Inc. (ABKI)      (\"Abakan\")      a nanotechnology materials company that designs, produces and      has recently commenced sales of protective coatings for      metal, metal formulations and advance energy management      solutions, announced today that it has filed an application      to list its common stock on the NASDAQ Capital Market. The      NASDAQ listing application is subject to review and approval      by NASDAQ's Listing Qualifications Department for compliance      with all NASDAQ Capital Market Standards.    <\/p>\n<p>      Robert Miller, Abakan's CEO, commented: \"Abakan is ready to      list on a larger, higher profile exchange and believes that      NASDAQ is the right marketplace for our shares to trade given      the focus on technology based companies. Listing on NASDAQ      should enable us to broaden our investor reach, increase      visibility in the investment community and add liquidity to      our shares.\"    <\/p>\n<p>      About Abakan Inc.    <\/p>\n<p>            Abakan, Inc. is a publicly listed acquisition company      that provides critical financial, management and intellectual      support to innovative companies and technologies for      realizing their true market potential.       Abakan invests in companies that have developed      transformational technologies on the cusp of      commercialization.       Abakan is the largest shareholder in       MesoCoat and       Powdermet, each of which is a nanotechnology material      science company involved in technology development and      commercialization.       MesoCoat is focused on metal asset protection and life      extension by providing advanced wear and corrosion solutions,      while       Powdermet is focused on metal formulations as well as      advanced energy management solutions.       MesoCoat was recently recognized by Forbes as one of      'The      Most Promising American Companies' and was the highest      ranked material science and nanotechnology company.       MesoCoat is also the recipient of four prestigious            R&D 100 awards, a       Technology Innovation Program Award (TIP) for 100 year      life coatings by the National Institute of Standards and      Technology (NIST), two       NorTech Innovation Awards for breakthrough materials and      surface engineering solutions, and several other federal and      state grants and awards.       Powdermet is a nationally recognized nanotechnology and      advanced materials research and development organization that      has won approximately 100 federal and state awards, along      with being a recipient of several technology innovation      awards like       R&D 100 and       NorTech Innovation Award.    <\/p>\n<p>      The Abakan, Inc. logo is available at       <a href=\"http:\/\/www.globenewswire.com\/newsroom\/prs\/?pkgid=14954\" rel=\"nofollow\">http:\/\/www.globenewswire.com\/newsroom\/prs\/?pkgid=14954<\/a>    <\/p>\n<p>      Forward Looking Statements    <\/p>\n<p>      A number of statements contained in this press release are      forward-looking statements. These forward looking statements      involve a number of risks and uncertainties including      technological obsolescence, market acceptance of future      products, competitive market conditions, NASDAQ approval for      listing of our common stock on the NASDAQ Capital Market, and      the sufficiency of capital resources. The actual results      Abakan may achieve could differ materially from any      forward-looking statements due to such risks and      uncertainties. Abakan encourages the public to read the      information provided here in conjunction with its most recent      filings on Form 10-K and Form 10-Q. Abakan's public filings      may be viewed at       <a href=\"http:\/\/www.sec.gov\" rel=\"nofollow\">http:\/\/www.sec.gov<\/a>.    <\/p>\n<\/p>\n<p>Read the original:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/abakan-files-nasdaq-tm-capital-130000220.html;_ylt=A2KJjbyp.WpQRQ4A6dv_wgt.\" title=\"Abakan Files for NASDAQ(TM) Capital Market Listing\">Abakan Files for NASDAQ(TM) Capital Market Listing<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> MIAMI, Fla., Oct. 1, 2012 (GLOBE NEWSWIRE) -- Abakan Inc. (ABKI) (\"Abakan\") a nanotechnology materials company that designs, produces and has recently commenced sales of protective coatings for metal, metal formulations and advance energy management solutions, announced today that it has filed an application to list its common stock on the NASDAQ Capital Market <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanotechnology\/abakan-files-for-nasdaqtm-capital-market-listing.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[7],"tags":[],"class_list":["post-53315","post","type-post","status-publish","format-standard","hentry","category-nanotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/53315"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=53315"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/53315\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=53315"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=53315"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=53315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}